Persistence Market Research
The demand within the global automated insulin delivery systems market has been rising on account of the rising incidence of diabetes across the globe. Irregular spikes in insulin levels can pose serious problems for the suffering individuals, and this factor has played a major role in the growth of the global automated insulin delivery system market. Furthermore, the need for improved insulin delivery systems also stems from the presence of an expansive industry for diabetes treatment and testing. The most distinct trait of insulin delivery systems is their ability to self-adjust the amount of insulin to be delivered. These systems come in the form of wearable devices that can measure the level or glucose in the body, and act according to it. Hence, the global demand for automated insulin delivery systems market is projected to increase at a starry rate in the years to come.
Patients suffering from diabetes often get tired of the hassles of measuring their blood sugar levels and getting injections for insulin. In this scenario, an automated insulin delivery system helps in establishing a connection between the glucose level and the insulin required by the body. Hence, the ease offered by automated insulin delivery system is projected to propel demand within the global automated insulin delivery systems market.
On the basis of geography, the global automated insulin delivery systems market for automated insulin delivery system can be segmented into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. The automated insulin delivery systems market in North America is expanding alongside advancements in the domain of diabetes testing and treatment.
The automated insulin delivery systems, also known as artificial pancreas or hybrid closed loop automatically manages or withholds insulin in response to blood glucose measurements (via using continuous glucose monitors (CGMs) and smart algorithms). The objective of automated insulin delivery systems is to decrease hypoglycemia and reduce hyperglycemia – particularly overnight. There are various automated insulin delivery system (AID) frameworks being developed. A framework that computerizes basal insulin conveyance has effectively received Food and Drug Administration approval (Medtronic’s MiniMed 670G hybrid closed-loop system), and more systems are probably going to get approval during the forecast period. Type I diabetes is one of the chronic and life-threatening diseases that affect a large population of the world. According to JRDF (Juvenile Diabetes Research Foundation), presently around 1.25 million individuals have type 1 diabetes in the U.S., including 200,000 children. AID includes continuous glucose monitoring values bolstering into a closed loop control algorithm running on an insulin pump (inserted automated insulin delivery). Propelled calculations commonly utilize CGM information, input from insulin conveyance (e.g., insulin-on-board, or IOB, computation), and possibly different signs to adjust the insulin delivery rate in the adjusted time. Because of its guarantee to streamline diabetes control, AID may soon develop as the standard of administration to overseeing type 1 diabetes.
Automated insulin delivery systems Market: Segmentation
Automated insulin delivery systems market is segmented on the basis of the products, disease indication, distribution channel and regions:
On the basis of disease indications, the market is segmented into the following:
On the basis of distribution channel, the market is segmented into the following:
Automated Insulin Delivery Systems Market: Dynamics
Automated insulin delivery systems market is a rising market which is mainly driven by the rising prevalence of type I diabetes. High investment in R&D for new technology assessment, automation of medical devices and increasing awareness programs by various companies is further going to spur revenue growth for automated insulin delivery systems during the forecast period. Increased sales and marketing via top medical technology companies for automated insulin delivery devices which is available now worldwide at a reasonable cost is a driving factor. For e.g. In January 2017, Bigfoot Biomedical raised money for its smart insulin delivery system.
However, diabetes is largely undiagnosed in the overall population worldwide. Automated insulin delivery systems market surfaces few challenges and risks due to availability of disposable insulin delivery systems which capture huge market share in the international market. Few limitations include pump imprecision, sensor inaccuracy/unreliability. Still many people are struggling to maintain good glycemic control. Top manufacturing firms which are involved in production of automated insulin- delivery systems, however stringent regulatory framework and complications in adopting new technology assessment in the production process hinders the growth of these manufacturers.
Automated insulin delivery systems Market: Region-wise Outlook
Based on geography, the automated insulin delivery systems market can be segmented into seven major regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. At present, North America holds a leading position in the automated insulin delivery systems market. Involvement of leading players in the new product development and up gradation of new insulin pumps to enhance their product portfolio with automated features in the international market. European manufacturers are also anticipated to show steady growth in the testing and approval for automated insulin delivery systems market. In the next few remarkable years, Japan, China and India would show notable growth in the automated insulin delivery systems market as it is developing at a healthy pace and has shown the appearance of numerous top medical device manufacturers. Rising type I diabetes, approval of new automated insulin delivery systems, CGM devices and new applications in the medical devices are further going to spur revenue growth during the global automated insulin delivery systems market.
Automated insulin delivery systems Market: Key Players
It is expected that with due course of time, there will be an influx of many players in the automated insulin delivery systems market. Major player operating in the automated insulin delivery systems market is Medtronic. Others are in pipeline including Eli Lily, Tandem, Insulet, Big Foot Biomedical and many others.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.